Clinical trial · Interventional
Development of Clinical and Biological Database
Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The BCB is a tool: * for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials; * to help scientists understand and explain phenomena ranging from the interaction of molecules to the whole metabolism of the organism in normal and pathological situations; * to identify potential strategies for prevention, diagnosis, management and analysis of cancer subtypes. The creation of a broad clinical and biological prospective base dedicated to different types of cancer is essential for the development of such projects.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Digestive Cancer | — | UNRESOLVED | — |
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biological collection | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Biological collection
- description
- samples of different natures: * Tissue samples (tumor tissue and healthy tissue) frozen and secured in paraffin collected during surgery. * Blood samples taken at different times. During the blood samples taken for diagnosis and / or treatment, additional samples for research purposes will be carried out. In parallel to this biological collection, standardized clinical data will be entered into a database
- interventionNames
- Biological: biological collection
Primary outcomes (1)
- measure
- Proportion of patients who consent to participate in the study
- timeFrame
- through study completion, an average of 1 year
- description
- the proportion of patients who consent to participate in the study among the screened patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age\> at 18 years old, * Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded, * Patient in ICM at diagnosis * a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or * gynecological cancer (ovary, endometrium, cervix) or * breast cancer or * sarcoma. * Naïve patient of any treatment for the present cancer, * Patient requiring treatment involving at least one (or more) tumor surgery (s) * Patient who has accepted supplementary blood samples, * Patient having given his informed, written and express consent. Exclusion Criteria: * Patient not affiliated to a social protection scheme, * Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons, * Pregnant and / or nursing women, * Subject under tutelage, curatorship or safeguard of justice, * Patient in an emergency situation.
References
Publications (0)
Data not yet available